A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG von Miranda, Jamilet, Vázquez-Blomquist, Dania, Bringas, Ricardo, Fernandez-de-Cossio, Jorge, Palenzuela, Daniel, Novoa, Lidia I, Bello-Rivero, Iraldo

Volltext

A co-formulation of interferons type I and II enhances temozolomide response in glioblastoma with unmethylated MGMT promoter status von Vázquez-Blomquist, Dania, Leenstra, Sieger, van der Kaaij, Mariëlle, Villarreal, Adelaida, Bello-Rivero, Iraldo

Volltext

Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG von Vázquez-Blomquist, Dania, Hardy-Sosa, Anette, Baez, Saiyet C, Besada, Vladimir, Palomares, Sucel, Guirola, Osmany, Ramos, Yassel, Wiśniewski, Jacek R, González, Luis Javier, Bello-Rivero, Iraldo

Volltext

Combinación de interferones en pacientes con tumores cerebrales de alto grado de malignidad sin opciones terapéuticas von Bello-Rivero, Iraldo, Ríos-Cabrera, María Margarita, Cruz-Rodríguez, Javier

Volltext

HeberFERON en el tratamiento de pacientes con carcinoma basocelular en zona de alto riesgo von Sánchez Linares, Vladimir, Martínez Fando, Belkys, Carpio Muñoz, Emilio, Durán Marrero, Karel, Brito García, Elizabeth, Bello Rivero, Iraldo

Volltext

Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study von Anasagasti-Angulo, Lorenzo, Garcia-Vega, Yanelda, Barcelona-Perez, Silvia, Lopez-Saura, Pedro, Bello-Rivero, Iraldo

Volltext

The amino‐terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: internalization is toxin mediated von Fabbrini, M. Serena, Carpani, Daniela, Bello‐Rivero, Iraldo, Soria, Marco R.

Volltext

Carcinoma basocelular de la piel cabelluda tratado con HeberFERON. Seguimiento clínico, ecográfico e histopatológico von Sánchez Linares, Vladimir, Cabrera Naranjo, Diana Luisa, Amaró Garrido, Miguel Ángel, Tamayo Pérez, Olivia María, Casanova Cruz, Marisely, Bello Rivero, Iraldo

Volltext

HeberFERON en el carcinoma basocelular periocular. Serie de casos von Sánchez Linares, Vladimir, Ríos Rodríguez, María Elena, Román Simón, Maylin, Pérez García, Claritza Damaris, Díaz Hernández, Yaniset, Bello-Rivero, Iraldo

Volltext

Seguridad del HeberFERON( en pacientes con carcinoma basal palpebral von Rojas Rondón, Irene, Vigoa Aranguren, Lázaro, García Vega, Yanelda, Bello Rivero, Iraldo, Duncan Roberts, Yaquelín

Volltext

Respuesta clínica del tratamiento con HerberFERON( en pacientes con carcinoma basal palpebral von Rojas Rondón, Irene, Vigoa Aranguren, Lázaro, Garcìa Vega, Yanelda, Bello Rivero, Iraldo, Duncan Roberts, Yaquelin

Volltext

HeberFERON, a promising choice for the treatment of basal cell carcinoma von Bello Rivero, Iraldo

Volltext

Síndrome de Gorlin Goltz. A propósito de un caso von Sánchez Linares, Vladimir, Rodríguez Montagne, Daniel, Cifuentes Suárez, Juan Pablo, Román Simón, Maylin, Pérez Garcia, Claritza, Bello Rivero, Iraldo

Volltext

Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study von García-García, Idrian, González-Delgado, Carlos A, Valenzuela-Silva, Carmen M, Díaz-Machado, Alina, Cruz-Díaz, Marisol, Nodarse-Cuní, Hugo, Pérez-Pérez, Orlando, Bermúdez-Badell, Cimara H, Ferrero-Bibilonia, Joel, Páez-Meireles, Rolando, Bello-Rivero, Iraldo, Castro-Odio, Fidel R, López-Saura, Pedro A

Volltext

HeberFERON in the treatment of patients with basal cell carcinoma of the ear von Vladimir Sánchez Linares, Elizabeth Brito García, Belkys Martínez Fando, Yoelvis Álvarez Gómez, Iraldo Bello Rivero

Volltext

BioHabana 2022: Preventive and Immunotherapeutic Strategies Against COVID-19 and Cancer in Cuba von Bello-Rivero, Iraldo, Crombet-Ramos, Tania, Mesa-Pardillo, Circe, Morera-Díaz, Yanelys, Mazorra-Herrera, Zaima, Garcia-Rivera, Dagmar, Nodarse-Cuní, Hugo, Hernández-Bernal, Francisco, Muzio-Gonzalez, Verena, Aguilera-Barreto, Ana, Vazquez-Blomquist, Dania, Domínguez-Horta, Maria Del Carmen, Guillen-Nieto, Gerardo

Volltext

Characterization of the immunoreactivity of anti-interferon alpha antibodies in myasthenia gravis patients. Epitope mapping von Bello-Rivero, Iraldo, Cervantes, Majel, Torres, Yeny, Ferrero, Joel, Rodrı́guez, Eulises, Pérez, Jesús, Garcı́a, Idrian, Dı́az, Gisou, López-Saura, Pedro

Volltext

HeberFERON, a new formulation of IFNs with improved pharmacodynamics: Perspective for cancer treatment von Bello-Rivero, Iraldo, Garcia-Vega, Yanelda, Duncan-Roberts, Yaquelin, Vazquez-Blomquistc, Dania, Santana-Milian, Hector, Besada-Perez, Vladimir, Rios-Cabrera, Margarita

Volltext

Treatment of Basal Cell Carcinoma with Interferons Alpha-2b and Gamma in Primary Care von Fernández-Martori, Meilyn, Bello-Rivero, Iraldo, Duncan-Roberts, Yaquelín

Volltext

HeberFERON y calidad de vida en el carcinoma basocelular facial von Vladimir Sánchez Linares, Iraldo Bello Rivero

Volltext